Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

This doctor is against medical marijuana. Here’s why.

Michael Kirsch, MD
Meds
September 26, 2016
Share
Tweet
Share

I have already opined on my disapproval of a medical marijuana law recently passed in Ohio.  Once of my points in that piece is that I did not want legislators making medical decisions for us.  They can’t even do their own jobs.

I am not against medical marijuana; I am for science.  The currency of determining the safety and efficacy of a medicine should be medical evidence, not faith, hope or belief.

Marijuana is a Drug Enforcement Agency (DEA) Schedule 1 drug, alongside heroin, LSD, and ecstasy.  I realize this seems odd since most of us do not believe that marijuana has the health or addictive risks of the other agents on the list.  It doesn’t.  But, danger is not the only criteria used in determining which category a drug belongs in, a point often misunderstood or ignored by medical marijuana enthusiasts.  An important criterion of Schedule 1 drugs is that they are deemed to have no proven medical use.

The federal government recently affirmed marijuana’s Schedule 1 status, which disappointed those who argue that this agent is the panacea, or at least an effective treatment, for dozens of ailments.  The government disagreed.  It reviewed several hundred medical studies and only identified 11 of them that were of sufficient scientific quality worthy of consideration.  None of them demonstrated a salutary effect of marijuana.

An advocate of medical marijuana use was railing against this decision and stated that 80 percent of Americans believed marijuana had medical value.  His point demonstrates the vacuousness of his argument.  He might support letting polling determine if a drug is safe and effective; but I trust the FDA and hard science to make these determinations.

I am sure that if we polled the public on the medical benefits of probiotics, gluten restriction, GMO foods,  organic foods, radiated foods, colonic detoxification, yoga, veganism and meditation that we might find that the public’s belief in these practices doesn’t have firm scientific support.   I do not argue that these dietary and lifestyle practices do not have health benefits or enhance life in other ways, only that they are either unproven or disproven.  There are still folks out there who believe that the measles vaccine causes autism, even though this theory has been thoroughly debunked. In my view, releasing a medicine to market requires firm scientific support.  Anecdotes and low-quality “studies” should be afforded the weight they deserve.

Should we open up the gates to all kinds of potions and elixirs that are unproven for the public?  We do!  They are called dietary supplements.  These agents are considered safe until they are proven to be dangerous.  Is this the standard we want for prescription drugs?

Michael Kirsch is a gastroenterologist who blogs at MD Whistleblower.

Image credit: Shutterstock.com

Prev

What's wrong with socialized medicine, and what we can learn from the NHS

September 26, 2016 Kevin 38
…
Next

The complications of firing patients who won't vaccinate

September 26, 2016 Kevin 3
…

Tagged as: Medications

Post navigation

< Previous Post
What's wrong with socialized medicine, and what we can learn from the NHS
Next Post >
The complications of firing patients who won't vaccinate

ADVERTISEMENT

More by Michael Kirsch, MD

  • Are Ozempic patients on a slow-moving runaway train?

    Michael Kirsch, MD
  • AI-driven diagnostics and beyond

    Michael Kirsch, MD
  • The surprising truth behind virtual visits

    Michael Kirsch, MD

Related Posts

  • Many questions remain about medical marijuana

    Steven Reznick, MD
  • The thorny side of medical marijuana

    Barbara Ficarra, RN, MPA
  • Qualifying conditions for medical marijuana

    Patricia Frye
  • Digital advances in the medical aid in dying movement

    Jennifer Lynn
  • International medical graduates ease the U.S. doctor shortage

    G. Richard Olds, MD
  • Many medical marijuana program websites are silent about possible risks

    Erik Messamore, MD, PhD

More in Meds

  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • “The meds made me do it”: Unpacking the Nick Reiner tragedy

    Arthur Lazarus, MD, MBA
  • Most Popular

  • Past Week

    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy
    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why the primary care system failure forces unnecessary referrals

      Jordan Cantor, DO | Physician
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why the primary care system failure forces unnecessary referrals

      Jordan Cantor, DO | Physician
    • AI in medicine vs. aviation: Why the autopilot metaphor fails

      Arthur Lazarus, MD, MBA | Physician
    • How the mind-body split in medicine shaped modern clinical care

      Robert C. Smith, MD | Conditions
    • Racial mistaken identity in medicine: a pervasive issue in health care

      Aba Black, MD, MHS | Physician
    • Artificial intelligence demands that doctors become architects of digital health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is testosterone replacement safe after prostate cancer surgery?

      Francisco M. Torres, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 27 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy
    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why the primary care system failure forces unnecessary referrals

      Jordan Cantor, DO | Physician
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why the primary care system failure forces unnecessary referrals

      Jordan Cantor, DO | Physician
    • AI in medicine vs. aviation: Why the autopilot metaphor fails

      Arthur Lazarus, MD, MBA | Physician
    • How the mind-body split in medicine shaped modern clinical care

      Robert C. Smith, MD | Conditions
    • Racial mistaken identity in medicine: a pervasive issue in health care

      Aba Black, MD, MHS | Physician
    • Artificial intelligence demands that doctors become architects of digital health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is testosterone replacement safe after prostate cancer surgery?

      Francisco M. Torres, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

This doctor is against medical marijuana. Here’s why.
27 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...